Zobrazeno 1 - 10 of 892 pro vyhledávání: '"Nouhin J"'
1
Akademický článek
Development and field evaluation in African and Asian countries of an hepatitis B virus PCR on open polyvalent platforms to determine treatment eligibility: results from the "Agence Nationale de Recherche sur le Sida et les hépatites" 12327 study.
Autor: Kania D; Department of Biomedical Sciences, Laboratoire de Virologie, Centre Muraz, Bobo-Dioulasso, Burkina Faso., Nouhin J; Virology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Bolloré K; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France., Njouom R; Virology Unit, Centre Pasteur of Cameroon, Yaounde, Cameroon., Toni TD; CeDReS, CHU de Treichville, Abidjan, Cote d'Ivoire., Maiga AI; University Research and Clinical Center, University of Sciences Techniques and Technologies of Bamako, Bamako, Mali., Toure-Kane C; Laboratoire de Bactériologie-Virologie, CHU Aristide le Dantec, Dakar, Senegal., Ngo-Giang-Huong N; MIVEGEC UMR IRD224-CNRS5290, Institut de Recherche pour le Développement (the French National Research Institute for Sustainable Development), Montpellier, France; LMI PRESTO, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand., Dagnra A; Centre National de Référence VIH-IST/PNLS, BIOLIM, FMMP/UL, Lomé, Togo., Chuong Le DH; Department of Biomedical, Food Analysis and Health Service, Ho Chi Minh City Pasteur Institute, Ho Chi Minh City, Viet Nam., Lunel-Fabiani F; Laboratory of Virology, University Hospital & LUNAM University and HIFIH Laboratory, UPRES EA 3859, Angers, France., Castera-Guy J; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France., Rubbo PA; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France; Omunis, Montpellier, France., Pisoni A; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France; Department of Virology, CHU de Montpellier, Montpellier, France., Plantier JC; Laboratoire de Virologie, CHU Charles Nicolle, Rouen, France., Tuaillon E; Pathogenesis and Control of Chronic and Emerging Infections, Université de Montpellier, INSERM, EFS, Université des Antilles, Montpellier, France; Department of Virology, CHU de Montpellier, Montpellier, France. Electronic address: e-tuaillon@chu-montpellier.fr.
Publikováno v: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Aug; Vol. 30 (8), pp. 1067-1073. Date of Electronic Publication: 2024 May 11.
Zobrazit plný text záznamu
3
Akademický článek
Human immunodeficiency virus 1 5'-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations.
Autor: Nouhin J; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA.; Virology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Tzou PL; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA., Rhee SY; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA., Sahoo MK; Department of Pathology, Stanford University, Stanford, CA, USA., Pinsky BA; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA.; Department of Pathology, Stanford University, Stanford, CA, USA., Krupkin M; Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA, USA., Puglisi JD; Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA, USA., Puglisi EV; Department of Structural Biology, School of Medicine, Stanford University, Stanford, CA, USA., Shafer RW; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA.
Publikováno v: The Journal of general virology [J Gen Virol] 2023 Oct; Vol. 104 (10).
Zobrazit plný text záznamu
4
Akademický článek
Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance.
Autor: Liu C; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.; School of Life Science and Technology, ShanghaiTech University, Shanghai, China., Guo M; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China., Han L; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China., Lu J; Department of Infectious Disease, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Xiang X; Department of Infectious Disease, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Xie Q; Department of Infectious Disease, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., Nouhin J; Virology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.; Sequencing Platform, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Duong V; Virology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia.; Sequencing Platform, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Tong Y; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China., Zhong J; Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.; Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
Publikováno v: Journal of medical virology [J Med Virol] 2023 Sep; Vol. 95 (9), pp. e29103.
Zobrazit plný text záznamu
5
HIV-1 5'-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations.
Autor: Nouhin J; Division of Infectious Diseases, Stanford University, Stanford, CA, USA and Virology Unit, Institut Pasteur du Cambodge, Pasteur Network, Phnom Penh, Cambodia., Tzou PL; Division of Infectious Diseases, Stanford University, Stanford, CA, USA., Rhee SY; Division of Infectious Diseases, Stanford University, Stanford, CA, USA., Sahoo MK; Department of Pathology, Stanford University, Stanford, CA, USA., Pinsky BA; Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA, USA; Department of Pathology, Stanford University, Stanford, CA, USA., Krupkin M; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Puglisi JD; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Puglisi EV; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, USA., Shafer RW; Division of Infectious Diseases, Stanford University, Stanford, CA, USA.
Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Aug 29. Date of Electronic Publication: 2023 Aug 29.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
Autor: DeVos J; International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Preventiongrid.416738.f (CDC), Atlanta, Georgia, USA., McCarthy K; CDC Kenya, Nairobi, Kenya., Sewe V; HIV Research Laboratory, Kenya Medical Research Institute-Center for Global Health Research, Kisumu, Kenya., Akinyi G; HIV Research Laboratory, Kenya Medical Research Institute-Center for Global Health Research, Kisumu, Kenya., Junghae M; CDC Kenya, Nairobi, Kenya., Opollo V; HIV Research Laboratory, Kenya Medical Research Institute-Center for Global Health Research, Kisumu, Kenya., Nouhin J; Stanford University, Stanford, California, USA., Shafer R; Stanford University, Stanford, California, USA., Zeh C; International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Preventiongrid.416738.f (CDC), Atlanta, Georgia, USA., Ramos A; International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Preventiongrid.416738.f (CDC), Atlanta, Georgia, USA., Alexander H; International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Preventiongrid.416738.f (CDC), Atlanta, Georgia, USA., Chang J; International Laboratory Branch, Division of Global HIV and Tuberculosis (TB), Center for Global Health, Centers for Disease Control and Preventiongrid.416738.f (CDC), Atlanta, Georgia, USA.
Publikováno v: Microbiology spectrum [Microbiol Spectr] 2022 Jun 29; Vol. 10 (3), pp. e0177621. Date of Electronic Publication: 2022 May 05.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje